Format

Send to

Choose Destination
Am J Sports Med. 2015 Jun;43(6):1362-72. doi: 10.1177/0363546515574063. Epub 2015 Mar 17.

Prospective clinical and radiologic evaluation of patellofemoral matrix-induced autologous chondrocyte implantation.

Author information

1
School of Sport Science, Exercise and Health, University of Western Australia, Perth, Australia jay.ebert@uwa.edu.au.
2
Perth Radiological Clinic, Perth, Australia.
3
The School of Physiotherapy and Curtin Health Innovation Research Institute, Curtin University, Perth, Australia.
4
Perth Orthopaedic and Sports Medicine Centre, West Perth, Australia.
5
School of Surgery (Orthopaedics), University of Western Australia, Perth, Australia.

Abstract

BACKGROUND:

While matrix-induced autologous chondrocyte implantation (MACI) has demonstrated encouraging outcomes in the treatment of knee chondral defects, there remains little available research specifically investigating its use in the patellofemoral joint.

PURPOSE:

To prospectively evaluate the clinical and radiologic outcome of MACI in the patellofemoral joint.

STUDY DESIGN:

Case series; Level of evidence, 4.

METHODS:

In 47 consecutive patients undergoing patellofemoral MACI, clinical (Knee injury and Osteoarthritis Outcome Score, 36-Item Short Form Health Survey, visual analog scale for pain, 6-minute walk test, knee range of motion, and strength assessment) and magnetic resonance imaging (MRI) assessments were undertaken before and 3, 12, and 24 months after surgery. The MRI was performed to assess graft infill and determine an overall MRI composite score. Results were analyzed according to (1) the patient sample overall and (2) after stratification into 4 subgroups per implant location (patella or trochlea) as well as whether or not adjunct tibial tubercle transfer for patellofemoral malalignment was required.

RESULTS:

The overall patient sample, as well as each of the 4 procedural subgroups, demonstrated clinically and statistically significant (P < .05) improvements over time for all clinical scores. Graft infill and the MRI composite score also demonstrated statistically significant (P < .05) improvements over time, with no evidence of a main effect for procedure group or interaction between procedure group and time. At 24 months after surgery, 40.4% (n = 19) of patients exhibited complete graft infill comparable with the adjacent native cartilage, with a further 6.4% (n = 3) demonstrating a hypertrophic graft. A further 31.9% (n = 15) of patients exhibited 50% to 100% tissue infill, and 17% (n = 8) demonstrated <50% tissue infill. Two patients (4.3%) demonstrated graft failure. At 24 months after surgery, 85% (n = 40) of patients were satisfied with the results of their MACI surgery.

CONCLUSION:

These results demonstrate that MACI provides improved clinical and radiologic outcomes to 24 months in patients undergoing treatment specifically for articular cartilage defects on the patella or trochlea, with and without concurrent realignment of the extensor mechanism if required.

KEYWORDS:

clinical outcomes; magnetic resonance imaging; matrix-induced autologous chondrocyte implantation; patellofemoral joint

PMID:
25784629
DOI:
10.1177/0363546515574063
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center